Update: 07.10.2025
Last week: 39 week 2025 (22.09.2025 - 28.09.2025)
Last full month: August 2025
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 9 769 | -4.2% | 14.0% | 0.3 | 22 377 464 | -4.1% | 10.5% | 0.3 | -6.1% |
| MoM | 36 668 | 3.5% | 14.1% | 0.1 | 84 968 932 | 3.2% | 10.6% | -0.1 | 2.8% |
| YTD | 348 697 | 19.8% | 13.3% | 1.4 | 781 304 243 | 28.8% | 10.0% | 0.5 | 7.1% |
| MAT | 479 099 | 21.5% | 13.3% | 2 | 1 014 022 006 | 23.9% | 9.7% | 0.6 | 3.1% |
| BRAINMAX | |||||||||
| WoW | 2 238 | -7.2% | 100.0% | 0 | 7 562 946 | -10.6% | 100.0% | 0 | -7.2% |
| MoM | 8 534 | 2.0% | 100.0% | 0 | 30 008 435 | 3.6% | 100.0% | 0 | 2.0% |
| YTD | 89 226 | 81.2% | 100.0% | 0 | 309 065 967 | 77.9% | 100.0% | 0 | 81.2% |
| MAT | 122 663 | 88.3% | 100.0% | 0 | 422 101 354 | 83.6% | 100.0% | 0 | 88.3% |
| GOLDLINE PLUS | |||||||||
| WoW | 11 812 | -3.3% | 44.4% | 0.1 | 40 076 305 | -2.7% | 37.1% | 0.1 | -3.4% |
| MoM | 56 909 | -3.8% | 45.9% | -0.9 | 188 693 462 | -2.8% | 37.6% | -0.8 | -2.0% |
| YTD | 590 348 | -8.0% | 45.8% | 0.7 | 1 917 869 536 | -4.9% | 37.5% | 0.6 | -9.5% |
| MAT | 777 673 | -6.8% | 46.0% | 0.7 | 2 503 382 715 | -5.0% | 37.6% | 0.1 | -8.3% |
| MIGRENIUM | |||||||||
| WoW | 8 973 | -9.3% | 0.4% | 0 | 3 299 713 | -9.2% | 0.5% | 0 | -8.8% |
| MoM | 35 983 | 7.1% | 0.3% | 0 | 12 764 211 | 6.9% | 0.5% | 0 | 4.2% |
| YTD | 320 302 | -28.7% | 0.4% | -0.2 | 113 360 697 | -19.6% | 0.5% | -0.2 | 4.8% |
| MAT | 438 616 | -26.0% | 0.4% | -0.1 | 154 017 817 | -10.5% | 0.5% | -0.1 | 2.6% |
| MODELAX-N | |||||||||
| WoW | 24 933 | -3.9% | 18.6% | -0.2 | 14 944 750 | -2.8% | 14.2% | 0 | -2.8% |
| MoM | 109 386 | -0.2% | 18.8% | -0.1 | 62 929 768 | 2.9% | 14.0% | 0.3 | 0.3% |
| YTD | 1 078 306 | -2.9% | 20.0% | -2.5 | 586 188 940 | 20.8% | 14.5% | 0 | 9.2% |
| MAT | 1 431 874 | 0.3% | 19.9% | -1.4 | 760 374 272 | 27.1% | 14.2% | 0.8 | 7.6% |
| REDUXIN | |||||||||
| WoW | 8 788 | -2.2% | 33.1% | 0.4 | 47 547 023 | -0.8% | 44.0% | 0.9 | -3.4% |
| MoM | 40 074 | 0.3% | 32.3% | 0.7 | 219 573 916 | 1.5% | 43.8% | 1 | -2.0% |
| YTD | 408 758 | -12.6% | 31.7% | -1.1 | 2 227 784 817 | -10.4% | 43.6% | -1.9 | -9.5% |
| MAT | 536 808 | -10.3% | 31.8% | -0.7 | 2 904 274 302 | -7.7% | 43.7% | -1.1 | -8.3% |
| REDUXIN FORTE | |||||||||
| WoW | 2 739 | -14.6% | 10.3% | -1.3 | 13 347 073 | -12.8% | 12.3% | -1.4 | -3.4% |
| MoM | 12 848 | -2.5% | 10.4% | -0.1 | 60 988 448 | -1.5% | 12.2% | -0.1 | -2.0% |
| YTD | 131 156 | 2.2% | 10.2% | 1.2 | 604 605 511 | 9.3% | 11.8% | 1.7 | -9.5% |
| MAT | 170 240 | 1.8% | 10.1% | 1 | 773 143 661 | 8.0% | 11.6% | 1.4 | -8.3% |
| SALVISAR | |||||||||
| WoW | 11 368 | -8.2% | 1.6% | 0 | 6 204 032 | -7.2% | 1.6% | 0 | -9.2% |
| MoM | 42 810 | 13.5% | 1.4% | 0.2 | 23 255 651 | 14.8% | 1.4% | 0.2 | 1.1% |
| YTD | 455 544 | 16.2% | 1.6% | 0.3 | 232 498 803 | 44.4% | 1.6% | 0.4 | -2.9% |
| MAT | 635 243 | 23.2% | 1.7% | 0.4 | 312 375 991 | 54.9% | 1.6% | 0.5 | -4.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 348 697 | 19.8% | 13.3% | 1.4 | 781 304 243 | 28.8% | 10.0% | 0.5 | 7.1% |
| BRAINMAX | 89 226 | 81.2% | 100.0% | 0 | 309 065 967 | 77.9% | 100.0% | 0 | 81.2% |
| GOLDLINE PLUS | 590 348 | -8.0% | 45.8% | 0.7 | 1 917 869 536 | -4.9% | 37.5% | 0.6 | -9.5% |
| MIGRENIUM | 320 302 | -28.7% | 0.4% | -0.2 | 113 360 697 | -19.6% | 0.5% | -0.2 | 4.8% |
| MODELAX-N | 1 078 306 | -2.9% | 20.0% | -2.5 | 586 188 940 | 20.8% | 14.5% | 0 | 9.2% |
| REDUXIN CAPS | 408 758 | -12.6% | 31.7% | -1.1 | 2 227 784 817 | -10.4% | 43.6% | -1.9 | -9.5% |
| REDUXIN FORTE | 131 156 | 2.2% | 10.2% | 1.2 | 604 605 511 | 9.3% | 11.8% | 1.7 | -9.5% |
| SALVISAR | 455 544 | 16.2% | 1.6% | 0.3 | 232 498 803 | 44.4% | 1.6% | 0.4 | -2.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 479 099 | 21.5% | 13.3% | 2 | 1 014 022 006 | 23.9% | 9.7% | 0.6 | 3.1% |
| BRAINMAX | 122 663 | 88.3% | 100.0% | 0 | 422 101 354 | 83.6% | 100.0% | 0 | 88.3% |
| GOLDLINE PLUS | 777 673 | -6.8% | 46.0% | 0.7 | 2 503 382 715 | -5.0% | 37.6% | 0.1 | -8.3% |
| MIGRENIUM | 438 616 | -26.0% | 0.4% | -0.1 | 154 017 817 | -10.5% | 0.5% | -0.1 | 2.6% |
| MODELAX-N | 1 431 874 | 0.3% | 19.9% | -1.4 | 760 374 272 | 27.1% | 14.2% | 0.8 | 7.6% |
| REDUXIN CAPS | 536 808 | -10.3% | 31.8% | -0.7 | 2 904 274 302 | -7.7% | 43.7% | -1.1 | -8.3% |
| REDUXIN FORTE | 170 240 | 1.8% | 10.1% | 1 | 773 143 661 | 8.0% | 11.6% | 1.4 | -8.3% |
| SALVISAR | 635 243 | 23.2% | 1.7% | 0.4 | 312 375 991 | 54.9% | 1.6% | 0.5 | -4.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 9 769 | -4.2% | 14.0% | 0.3 | 22 377 464 | -4.1% | 10.5% | 0.3 | -6.1% |
| BRAINMAX | 2 238 | -7.2% | 100.0% | 0 | 7 562 946 | -10.6% | 100.0% | 0 | -7.2% |
| GOLDLINE PLUS | 11 812 | -3.3% | 44.4% | 0.1 | 40 076 305 | -2.7% | 37.1% | 0.1 | -3.4% |
| MIGRENIUM | 8 973 | -9.3% | 0.4% | 0 | 3 299 713 | -9.2% | 0.5% | 0 | -8.8% |
| MODELAX-N | 24 933 | -3.9% | 18.6% | -0.2 | 14 944 750 | -2.8% | 14.2% | 0 | -2.8% |
| REDUXIN CAPS | 8 788 | -2.2% | 33.1% | 0.4 | 47 547 023 | -0.8% | 44.0% | 0.9 | -3.4% |
| REDUXIN FORTE | 2 739 | -14.6% | 10.3% | -1.3 | 13 347 073 | -12.8% | 12.3% | -1.4 | -3.4% |
| SALVISAR | 11 368 | -8.2% | 1.6% | 0 | 6 204 032 | -7.2% | 1.6% | 0 | -9.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 36 668 | 3.5% | 14.1% | 0.1 | 84 968 932 | 3.2% | 10.6% | -0.1 | 2.8% |
| BRAINMAX | 8 534 | 2.0% | 100.0% | 0 | 30 008 435 | 3.6% | 100.0% | 0 | 2.0% |
| GOLDLINE PLUS | 56 909 | -3.8% | 45.9% | -0.9 | 188 693 462 | -2.8% | 37.6% | -0.8 | -2.0% |
| MIGRENIUM | 35 983 | 7.1% | 0.3% | 0 | 12 764 211 | 6.9% | 0.5% | 0 | 4.2% |
| MODELAX-N | 109 386 | -0.2% | 18.8% | -0.1 | 62 929 768 | 2.9% | 14.0% | 0.3 | 0.3% |
| REDUXIN CAPS | 40 074 | 0.3% | 32.3% | 0.7 | 219 573 916 | 1.5% | 43.8% | 1 | -2.0% |
| REDUXIN FORTE | 12 848 | -2.5% | 10.4% | -0.1 | 60 988 448 | -1.5% | 12.2% | -0.1 | -2.0% |
| SALVISAR | 42 810 | 13.5% | 1.4% | 0.2 | 23 255 651 | 14.8% | 1.4% | 0.2 | 1.1% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N SOL RECTAL USE 12.9 MG/ML+102.6 MG/ML+625 MG/ML 5 ML #20"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N SOL RECTAL USE 12.9 MG/ML+102.6 MG/ML+625 MG/ML 5 ML #20"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs